|
| Indications |
• Treatment of malaria attacks
• Individual prophylaxis
|
|
| Pharmacological Class |
Amino-4 quinoline derivative
|
|
| Pharmacological Properties |
Schizonticide
|
|
| Mechanism of Action |
Schizonticide in the endo-erythrocyte phase. It has no action on the exo-erythrocyte forms that are fixed in the liver
|
|
| Side Effects |
Minor digestive disorders (nausea, anorexia)
|
|
| Contradictions |
• Hypersensitivity to one of the components
• History of liver and /or blood disorder at the time of the treatment.
|
|
| Observations |
• It exerts action on a number of strains of plasmodium falciparum resistant to chloroquine.
• To be taken after meals
|
|
|